Follow
Khalil Ahmed PhD
Khalil Ahmed PhD
Minneapolis VA Health Care System and University of Minnesota
Verified email at umn.edu
Title
Cited by
Cited by
Year
Joining the cell survival squad: an emerging role for protein kinase CK2
K Ahmed, DA Gerber, C Cochet
Trends in cell biology 12 (5), 226-230, 2002
5252002
Protein kinase CK2 in health and disease: CK2: a key player in cancer biology
JH Trembley, G Wang, G Unger, J Slaton, K Ahmed
Cellular and molecular life sciences 66, 1858-1867, 2009
3882009
Protein kinase CK2 signal in neoplasia
K Ahmed, S Tawfic, S Yu, H Wang, R Faust, A Davis
Histology and histopathology 16 (2), 573-582, 2001
3802001
Protein kinase CK2–a key suppressor of apoptosis
KA Ahmad, G Wang, G Unger, J Slaton, K Ahmed
Advances in enzyme regulation 48 (1), 179-187, 2008
2912008
The effects of long chain fatty acids on sodium plus potassium ion-stimulated adenosine triphosphatase of rat brain
K Ahmed, BS Thomas
Journal of Biological Chemistry 246 (1), 103-109, 1971
2301971
Emergence of protein kinase CK2 as a key target in cancer therapy
JH Trembley, Z Chen, G Unger, J Slaton, BT Kren, C Van Waes, K Ahmed
Biofactors 36 (3), 187-195, 2010
2242010
Ion transport and phosphoproteins of human red cells
JD Judah, K Ahmed, AEM McLean
Biochim. Biophys. Acta 65 (3), 472-480, 1962
2231962
Preparation of lipoproteins containing cation-dependent ATPase
K Ahmed, JD Judah
Biochimica et Biophysica Acta (BBA)-General Subjects 93 (3), 603-613, 1964
2201964
A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells
C Guo, S Yu, AT Davis, H Wang, JE Green, K Ahmed
Journal of Biological Chemistry 276 (8), 5992-5999, 2001
1912001
The biochemistry of sodium transport
JD Judah, K Ahmed
Biological Reviews 39 (2), 160-193, 1964
1901964
Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation
RA Faust, M Gapany, P Tristani, A Davis, GL Adams, K Ahmed
Cancer letters 101 (1), 31-35, 1996
1871996
Targeting CK2 for cancer therapy
KA Ahmad, G Wang, J Slaton, G Unger, K Ahmed
Anti-cancer drugs 16 (10), 1037-1043, 2005
1732005
Protein kinase CK2 as regulator of cell survival: implications for cancer therapy
GM Unger, AT Davis, JW Slaton, K Ahmed
Current cancer drug targets 4 (1), 77-84, 2004
1612004
NEK2A interacts with MAD1 and possibly functions as a novel integrator of the spindle checkpoint signaling
Y Lou, J Yao, A Zereshki, Z Dou, K Ahmed, H Wang, J Hu, Y Wang, X Yao
Journal of Biological Chemistry 279 (19), 20049-20057, 2004
1552004
CD66 family members are associated with tyrosine kinase activity in human neutrophils.
KM Skubitz, KD Campbell, K Ahmed, AP Skubitz
Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5382-5390, 1995
1541995
Nuclear casein kinase 2 (CK‐2) activity in human normal, benign hyperplastic, and cancerous prostate
S Yenice, AT Davis, SA Goueli, A Akdas, C Limas, K Ahmed
The Prostate 24 (1), 11-16, 1994
1521994
Downregulation of CK2 induces apoptosis in cancer cells–a potential approach to cancer therapy
G Wang, G Unger, KA Ahmad, JW Slaton, K Ahmed
Molecular and cellular biochemistry 274, 77-84, 2005
1472005
Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model
JW Slaton, GM Unger, DT Sloper, AT Davis, K Ahmed
Molecular Cancer Research 2 (12), 712-721, 2004
1472004
Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck
M Gapany, RA Faust, S Tawfic, A Davis, GL Adams, P Leder, K Ahmed
Molecular medicine 1, 659-666, 1995
1461995
Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways
T Afsar, JH Trembley, CE Salomon, S Razak, MR Khan, K Ahmed
Scientific reports 6 (1), 23077, 2016
1232016
The system can't perform the operation now. Try again later.
Articles 1–20